
    
      Patients with first attack of AP irrespective of etiology will be enrolled in the study, if
      they are eligible according to the following criteria:

      Inclusion criteria:

        -  onset of symptoms consistent with AP within 72 hours before admission to the hospital

        -  an 3-fold elevation of serum amylase or serum lipase over the upper limit of normal

        -  APACHE II score 6 or more

        -  a signed informed consent

      Exclusion criteria:

        -  patients < 18 years of age

        -  pregnant and breastfeeding women
    
  